A Quote by Andre Calantzopoulos

The potential of a zero-risk is in every market, because eventually I think people will switch to these products as they become available. There are two unmet needs in smokers: something that is much better for my health and something that bothers others much less or doesn't bother them. These are things cigarettes can't resolve. These new products are developed to address these needs.
When you look at the potential of such a zero-risk products as electronic cigarettes you need to understand what is the readiness of smokers to switch. That relates to public-health concerns, social pressure, concern for people around you and many other more subtle things. You cannot say that Indonesia is at the same level of readiness as the U.K, Western Europe or the U.S.
It's pretty clear that we will need measures to accelerate the conversion to new products. Governments can either make measures even worse for cigarettes or do something different on these new zero-risk products to show consumers they are different. I think they should do both.
Innovation, in the minds of people, cannot be something extremely cheap. If you are an average person and you hear that something that is much better than cigarettes comes to the market at the cheapest possible price, you'll not trust it. This is the reason we didn't initially manufacture in China, because you need to create that credibility. Over time you need to make the products available and affordable to different categories of people.
Shifting Philip Morris to the new a non-risk products doesn't mean that I will give market share to my competitors free of charge. In the markets where we are not present with IQOS yet or the other reduced-risk products, you still need to defend your share of the market. They still represent the bulk of our income, and so far they have financed the billions of dollars we have put behind these new products. But once we go national in a market, and absent capacity constraints, then you shift your resources and your focus to these new products.
New products, new markets, new investors, and new ways of doing things are the lifeblood of growth. And while each innovation carries potential risk, businesses that don't innovate will eventually diminish.
Nobody's more serious about health and fitness than me and staying fit is my top priority, That's why I've teamed up with Medifast to bring my fans a line of products that are packed with everything the body needs to get in better shape and improve their health. I use the products every day as part of my training.
I think over time the fiscal environment on cigarettes will become different, and the regulatory environment has to differentiate the products. If that is at the expense of cigarettes, so be it - it's not a problem for me. But we need some logical forum where we don't talk ideology but rather we talk about what can really accelerate the conversion. If you do display bans everywhere in the world on cigarettes but you can display IQOS, that's a differentiating measure for me. Then I'm more than willing to accept these measures because they are really conducive to make people switch.
The market is so competitive. There are so many products that are similar. So we are forced to invest in innovative research in new products that are one or two years ahead of the market.
We’re keenly aware that when we develop and make something and bring it to market that it really does speak to a set of values. And what preoccupies us is that sense of care, and what our products will not speak to is a schedule, what our products will not speak to is trying to respond to some corporate or competitive agenda. We’re very genuinely designing the best products that we can for people.
Pharmaceutical companies have too much influence over the education of physicians in this country. They have too much control over the evaluation of their own products, and that's a conflict of interest. I think the industry needs to be regulated, but I've never suggested taking it out of the market altogether.
The biggest weakness of the green-consumer movement, always, is that we tend to pick the easy-to-do things because that's where we can most readily engage people. It doesn't cost them very much to switch products or whatever it happens to be.
American products are better than the Chinese. We do a better job. We make better products. But because the currency is so low versus the dollar versus other things, and so much lower than it should be, it's very hard to compete for our companies.
Effective public-private partnerships will help drive the development of new products to meet the particular health needs of the poor and other vulnerable populations.
I switch my products so much, but right now, I'm really into organic skin care. I hope it's here to stay. I like that whole vibe and just being really gentle with your skin and not putting too much products that are harsh.
There is much that public policy can do to support American entrepreneurs. Health insurance reform will make it easier for entrepreneurs to take a chance on a new business without putting their family's health at risk. Tort reform will make it easier to take prudent risks on new products in a number of sectors.
If you have to ban something, ban products which are actually harmful for us, like cigarettes. Smoking also affects the health of people standing around you. But we won't ban such things. We're told don't eat fish, don't eat meat, don't wear miniskirts and other such things.
This site uses cookies to ensure you get the best experience. More info...
Got it!